Medical Cannabis Benefits: Evidence, Limits and Risks

Medical cannabis benefits: what the evidence actually shows

Medical cannabis consultation and evidence-based treatment discussion

“Medical cannabis” is not one treatment. Research may involve a purified cannabinoid, a standardised spray, a synthetic medicine or plant material with very different THC and CBD levels. Evidence for one preparation and diagnosis cannot be copied to every product, strain or symptom. A useful consultation starts with the condition, treatment goal, current medicines and risks—not with the most famous strain name.

Evidence in context

  • Some cannabinoid medicines have specific approved uses
  • Benefits for chronic or neuropathic pain are generally modest
  • Evidence for many popular wellness claims remains early or inconsistent
  • Side effects and medicine interactions matter

Where evidence is strongest

Specific prescription cannabinoid medicines

The US National Center for Complementary and Integrative Health notes approved cannabinoid medicines for certain rare seizure disorders, chemotherapy-related nausea and vomiting, and appetite or weight loss associated with HIV/AIDS. These are defined products and indications, not proof that all cannabis products treat the same conditions.

Chronic and neuropathic pain

Reviews summarised by NCCIH suggest a small or modest average benefit for some chronic pain and neuropathic pain outcomes. The difference from placebo can be limited, and adverse events are more common. A clinician should decide whether a trial has a realistic goal, such as improved sleep or function, and when to stop if it is not helping.

Multiple-sclerosis symptoms

Some cannabinoid preparations have been studied for spasticity or related symptoms. Results depend on the preparation and outcome measured. This does not justify replacing established treatment without a specialist.

Where claims often run ahead of research

Anxiety, sleep and mood

People report different experiences, but testimonial evidence is not the same as a controlled clinical result. THC may increase anxiety or impair sleep quality in some people, and frequent use can create tolerance. The underlying cause should be assessed first.

Cancer and other serious disease

Cannabinoids may be prescribed for particular treatment-related symptoms, but that is different from treating the cancer itself. Do not delay oncology, neurological or other evidence-based care because of an online claim.

THC, CBD and the product label

THC

THC can affect coordination, attention, memory and judgement. Higher amounts generally increase impairment and the chance of an unpleasant reaction.

CBD

CBD is not intoxicating in the same way, but it is not risk-free. NCCIH notes possible drowsiness, gastrointestinal effects, liver effects and interactions with medicines. Over-the-counter labels may not always match laboratory content.

Flower is variable

Two products sold under similar names can differ by batch, cannabinoid concentration, freshness and contaminants. Medical decisions should use the actual label, prescribed quantity and reliable testing where available.

Who needs extra caution

Pregnancy and breastfeeding, adolescence, a personal or family history of psychosis, cardiovascular problems, liver disease, fall risk and medicines with sedating or metabolic interactions all require professional review. Never drive or ride a scooter while impaired. Keep products locked away from children and pets.

What a useful medical consultation covers

  1. Your diagnosis and the symptom being targeted.
  2. What standard treatments have been tried and whether they helped.
  3. Current prescriptions, supplements, alcohol and other substances.
  4. The product, THC/CBD content, route and initial quantity.
  5. A measurable goal and a review date.
  6. Side effects and a clear reason to reduce or stop.

Sources and Thai context

The NCCIH evidence overview separates approved cannabinoid medicines, limited evidence and safety concerns. Thailand’s Division of Medical Cannabis describes professional oversight and medical-service standards in its 2026 implementation update. This article provides general education and does not diagnose or prescribe.

Frequently asked questions

Does medical cannabis work for everyone?

No. Response depends on the diagnosis, preparation, amount, other medicines and individual risk.

Is a high THC percentage medically better?

No. More THC usually means more impairment; the appropriate product is the one matched to a clinical goal and tolerability.

Can I stop my current medicine?

Do not stop or replace prescribed treatment without the clinician who manages it.

Start with the medical question

Read how a medical cannabis consultation in Phuket works and what the PT.33 form records.